AROLDI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 1.411
EU - Europa 1.028
AS - Asia 492
SA - Sud America 46
AF - Africa 10
OC - Oceania 1
Totale 2.988
Nazione #
US - Stati Uniti d'America 1.398
IT - Italia 447
SG - Singapore 232
DE - Germania 169
IE - Irlanda 133
CN - Cina 98
SE - Svezia 89
RU - Federazione Russa 66
HK - Hong Kong 60
BR - Brasile 32
ID - Indonesia 29
GB - Regno Unito 24
FI - Finlandia 22
IN - India 17
NL - Olanda 13
TR - Turchia 13
VN - Vietnam 13
FR - Francia 10
CA - Canada 9
AR - Argentina 8
ES - Italia 8
PT - Portogallo 8
CZ - Repubblica Ceca 7
UA - Ucraina 7
EG - Egitto 6
IR - Iran 6
AT - Austria 5
CO - Colombia 5
NO - Norvegia 5
PL - Polonia 5
BG - Bulgaria 3
IL - Israele 3
KG - Kirghizistan 3
AM - Armenia 2
AZ - Azerbaigian 2
IQ - Iraq 2
KR - Corea 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
MA - Marocco 2
MX - Messico 2
PH - Filippine 2
RS - Serbia 2
AL - Albania 1
AU - Australia 1
BO - Bolivia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
JO - Giordania 1
JP - Giappone 1
KE - Kenya 1
NP - Nepal 1
PA - Panama 1
PK - Pakistan 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 2.988
Città #
Ann Arbor 545
Singapore 149
Milan 139
Dublin 133
Frankfurt am Main 119
Chandler 86
New York 74
Fairfield 70
Wilmington 68
Woodbridge 62
Hong Kong 54
Santa Clara 52
Ashburn 39
Seattle 34
Houston 32
Shanghai 29
Jakarta 28
Princeton 24
Cambridge 20
Lissone 19
Monza 17
Helsinki 14
Los Angeles 14
Romola 14
Rome 13
Lawrence 12
Altamura 11
Guangzhou 11
Munich 11
Nuremberg 10
Beijing 9
Dallas 9
Bologna 8
Como 8
Dong Ket 8
Jacksonville 8
San Diego 8
Turin 8
Dearborn 7
Sesto San Giovanni 7
Boardman 6
Carate Brianza 6
Council Bluffs 6
Fremont 6
Lappeenranta 6
London 6
Seregno 6
Andover 5
Tianjin 5
Assago 4
Bonndorf 4
Cinisello Balsamo 4
Desio 4
Falls Church 4
Genoa 4
Lisbon 4
Lodz 4
Olomouc 4
Oslo 4
Pune 4
Sacramento 4
Tehran 4
Toronto 4
Agrate Brianza 3
Ankara 3
Arese 3
Bari 3
Bergamo 3
Berlin 3
Bishkek 3
Bogotá 3
Buenos Aires 3
Ceret 3
Chicago 3
Colorado Springs 3
Corbetta 3
Delhi 3
Kocaeli 3
Legnano 3
Lleida 3
Nanchang 3
Sacavém 3
Seriate 3
São Paulo 3
Tel Aviv 3
Usmate Velate 3
Aurora 2
Baghdad 2
Baku 2
Bhopal 2
Cesano Maderno 2
Cologne 2
Coventry 2
Dresden 2
Garbsen 2
Gorgonzola 2
Haikou 2
Hangzhou 2
Hounslow 2
Huizhou 2
Totale 2.188
Nome #
Chronic myeloid leukemia: Second-line drugs of choice 274
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia 202
Phase two study of crizotinib in patients with anaplastic lymphoma kinase (ALK) positive anaplastic large cell lymphoma relapsed/refractory to chemotherapy 200
Integrated Genomic, Functional and Prognostic Characterization of Atypical Chronic Myeloid Leukemia (aCML) in a Cohort of 43 Patients 199
Deferasirox in the management of iron-overload in patients with myelofibrosis: a multicentre study from the Rete Ematologica Lombarda (IRON-M study) 174
Clinical Benefit of Lenzilumab in Cases of Coronavirus Disease 2019 172
Evaluating the performance of large language models in haematopoietic stem cell transplantation decision-making 171
Long-term and low-dose of busulfan is a safe and effective second-line treatment in elderly patients with essential thrombocythemia resistant or intolerant to hydroxyurea 167
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis 163
Treatment of Philadelphia-negative myeloproliferative neoplasms in accelerated/blastic phase with azacytidine. Clinical results and identification of prognostic factors 161
Transfusion of blood products derived from SARS-CoV-2+ donors to patients with hematological malignancies 136
Idiopathic erythrocytosis: a germline disease? 123
Neurological symptoms in essential thrombocythemia: Impact of JAK2V617F mutation and response to therapy 121
Tyrosine Kinase Inhibitor discontinuation in Chronic Myeloid Leukemia: eligibility criteria and predictors of success 113
Characterization of SARS-CoV-2 Mutational Signatures from 1.5+ Million Raw Sequencing Samples 104
Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients 101
Iron chelation therapy with deferasirox in the management of iron overload in primary myelofibrosis 87
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia 75
Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID-19 vaccine: A single-center prospective observational study (NCT05074706) 73
Validation of a new NGS-based myeloid panel in acute myeloid leukemia: A single-center experience 71
A monocentric analysis of the long-term safety and efficacy of crizotinib in relapsed/refractory ALK+ lymphomas 67
Caution in using second generation tyrosine kinase inhibitor, especially for first line therapy of chronic myeloid leukemia 39
Hb Monza: A novel extensive HBB duplication with preserved α-β subunit interaction and unstable hemoglobin phenotype 37
Anaplastic Lymphoma Kinase (ALK) Inhibitors Enhance Phagocytosis Induced by CD47 Blockade in Sensitive and Resistant ALK-Driven Malignancies 24
Prognostic Biomarkers in Breast Cancer via Multi-Omics Clustering Analysis 18
ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells 8
Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic Hematopoietic Stem Cell Transplantation: Biology and Treatment Options 7
Advances and Hurdles in CAR T Cell Immune Therapy for Solid Tumors 5
Totale 3.092
Categoria #
all - tutte 12.812
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.812


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202034 0 0 0 0 0 0 0 0 11 13 5 5
2020/2021663 37 17 66 57 58 75 58 60 69 47 58 61
2021/2022295 52 36 48 38 14 23 4 8 7 10 17 38
2022/2023421 37 117 37 27 24 62 29 8 35 12 26 7
2023/2024650 14 20 30 27 61 175 96 25 67 42 26 67
2024/2025883 56 141 88 76 119 88 113 69 133 0 0 0
Totale 3.092